Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus

Autoimmunity Reviews

Volumn 10, Issue 7, 2011, Pages 432-437

  Newman, Kam A ^a   Akhtari, Mojtaba ^b  

^a JAMAICA HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Felty's syndrome; G CSF; Neutropenia; Systemic lupus erythematosus

Indexed keywords

ALKALINE PHOSPHATASE; AUTOANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; URIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LUNG INJURY; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTHRITIS; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BONE PAIN; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; FELTY SYNDROME; FLU LIKE SYNDROME; HUMAN; INFECTION RISK; MORBIDITY; MORTALITY; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NEUTROPHIL; RASH; RECURRENT INFECTION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEPSIS; SIDE EFFECT; SPLEEN RUPTURE; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS; URIC ACID BLOOD LEVEL;

AUTOIMMUNE DISEASES; FELTY'S SYNDROME; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEUTROPENIA;

EID: 79955106414     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.01.006     Document Type: Review

References (81)

1. Akhtari M., Curtis B., Waller E.K. Autoimmune neutropenia in adults. Autoimmun Rev 2009, 9:62-66.
2. Lalezari P. Neutropenia. The autoimmune diseases 2006, 585-589. Elsevier Inc, St Louis. 4th ed. N.R. Rose, I.R. Mackay (Eds.).
3. Lalezari P., Nussbaum M.G., Gelman S., Spaet T.H. Neonatal neutropenia due to maternal isoimmunization. Blood 1960, 15:236-243.
4. Lalezari P., Murphy G.B., Allen F.H. NB1, a new neutrophil-specific antigen involved in the pathogenesis of neonatal neutropenia. J Clin Invest 1971, 50:1108-1115.
5. Lalezari P., Jiang A.F., Yegen L., Santorineou M. Chronic autoimmune neutropenia due to anti-NA1 antibody. N Engl J Med 1975, 293:744-747.
6. Wiik A. Neutrophile-specific autoantibodies in chronic inflammatory bowel diseases. Autoimmun Rev 2002, 1:67-72.
7. Bux J. Molecular nature of antigens implicated in immune neutropenias. Int J Hematol 2002, 76(suppl (1):1399-1403.
8. Adamiak T., Gheller-Rigoni A., Arca M., Grossman W., Goday P.S. Perianal disease as the initial presentation of autoimmune neutropenia. J Pediatr Gastroenterol Nutr 2010, 50:99-102.
9. Shastri K.A., Logue G.L. Autoimmune neutropenia. Blood 1993, 81:1984-1995.
10. Chenoweth D.E., Cooper S.W., Hugli T.E., Stewart R.W., Blackstone E.H., Kirklin J.W. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981, 304:497-503.
11. Craddock P.R., Fehr J., Dalmasso A.P., Brighan K.L., Jacob H.S. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977, 59:879-888.
12. McCullough J, Press C, Clay M, Kline W, editors. Granulocyte serology: A clinical and laboratory guide. Chicago: ASCP Press; 1988. p. 90-112, 113-124, 134-135.
13. Logue G.L., Shastri K.A., Laughlin M., Shimm D.S., Ziolkowski L.M., Iglehart J.L. Idiopathic neutropenia: Antineutrophil antibodies and clinical correlations. Am J Med 1991, 90:211-216.
14. Wlodarski M.W., Nearman Z., Jiang Y., Lichtin A., Maciejewski J.P. Clonal predominance of CD8 (+) T cells in patients with unexplained neutropenia. Exp Hematol 2008, 36:293-300.
15. Clay M.E., Schuller R.M., Bachowski G.J. Granulocyte serology: current concepts and clinical significance. Immunohematology 2010, 26:11-21.
16. Hartman K.R., Wright D.G. Identification of autoantibodies specific for the neutrophil adhesion glycoproteins CD11b/CD18 in patients with autoimmune neutropenia. Blood 1991, 78:1096-1104.
17. Lalezari P., Khorshidi M., Petrosova M. Autoimmune neutropenia of infancy. J Pediar 1986, 109:764-769.
18. Lalezari P. Nomenclature for neutrophil-specific antigens. Transfusion 2002, 42:1396-1397.
19. Huizinga T.W.J., Kleijer M., Tetteroo P.A., Roos D., von dem Borne A.E. Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). Blood 1990, 75:213-217.
20. Bux J. Nomenclature of granulocyte alloantigens. ISBT Working Party on Platelet and Granulocyte Serology, Granulocyte Antigen Working Party. International Society of Blood Transfusion. Transfusion 1999, 39:662-663.
21. Bruin M.C., von dem Borne A.E., Tamminga R.Y., Kleijer M., Buddelmeijer L., de Haas M. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood 1999, 94:1797-1802.
22. Smith M.A., Smith J.G. The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia. Curr Opin Hematol 2001, 8:165-169.
23. Youinou P., Durand V., Renaudineau Y., Pennec Y.-L., Saraux A., Jamin C. Pathogenic effects of anti-Fc gamma receptor IIIb (CD 16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases. Autoimmun Rev 2002, 1:13-19.
24. Szekanecz E., Andras C., Sandor Z., Antal-Szalmas P., Szanto J., Tamasi L., et al. Malignancies and soluble tumor antigens in rheumatic diseases. Autoimmune Rev 2006, 6:42-47.
25. Reveille J. The genetic basis of antibody production. Autoimmun Rev 2006, 5:389-398.
26. Felty A.R. Splenomegaly and leucopenia: A report of five cases of an unusual clinical syndrome. Johns Hopkins Hosp Bull 1924, 35:16-20.
27. Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol 2002, 39:121-127.
28. Sibley J.T., Haga M., Visram D.A., Mitchell D.M. The clinical course of Felty's syndrome compared to matched controls. J Rheumatol 1991, 18:1163-1167.
29. Campion G., Maddison P.J., Goulding N., James I., Ahern M.J., Watt I., et al. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Med Baltim 1990, 69:69-80.
30. Dancey J.T., Brubaker L.H. Neutrophil marrow profiles in patients with rheumatoid arthritis and neutropenia. Br J Haematol 1979, 43:607-617.
31. Starkebaum G., Arend W.P., Nardella F.A., Gavin S.E. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome. J Lab Clin Med 1980, 96:238-251.
32. Meliconi R., Uguccioni M., Chieco-Bianchi F., Pitzalis C., Bowman S., Facchini A., et al. The role of interleukin-8 and other cytokines in the pathogenesis of Felty's syndrome. Clin Exp Rheumatol 1995, 13:285-291.
33. Hellmich B., Csernok E., de Haas M., von dem Borne A.E., Schatz H., Gross W.L., et al. Low Fc? receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus. Am J Med 2002, 113:134-139.
34. Ditzel H.J., Masaki Y., Nilesen H., Farnaes L., Burton D.R. Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome. Proc Natl Acad Sci USA 2000, 97:9234-9239.
35. Loughran T.P. Clonal diseases of large granular lymphocytes. Blood 1993, 82:1-14.
36. Lima M., Almeida J., Santos A.H. dos Anjos Teixeira M, Alguero MC, Queiros ML, Balanzategui A, Justica B, Gonzalez M, San Miguel JF, et al. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3 (+)/TCR-alphabeta (+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol 2001, 159:1861-1868.
37. Rose M.G., Berliner N. T-cell granular lymphocyte leukemia and related disorders. The Oncologist 2004, 9:247-258.
38. Burks E.J., Loughran T.P. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 2006, 20:245-266.
39. Liu J.H., Wei S., Epling-Burnette Lamy T., PK Starkebaum G., Djeu J.Y. Loughran TP Chronic neutropenia mediated by fas ligand. Blood 2000, 95:3219-3222.
40. Doria A., Canova M., Tonon M., Zen M., Rampudda E., Bassi N., et al. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 2008, 8:24-28.
41. Budman D.R., Steinberg A.D. Hematologic aspects of systemic lupus erythematosus: current concepts. Ann Intern Med 1977, 86:220-229.
42. Hadley A.G., Byran M.A., Chapel H., Bunch C., Holburn A.M. Antigranulocyte opsonic activity in sera from patients with systemic lupus erythematosus. Br J Haematol 1987, 65:61-65.
43. Courtney P.A., Crockard A.D., Williamson K., Irvine A.E., Kennedy R.J., Bell A.L. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999, 58:309-314.
44. Ren Y., Tang J., Mok M.Y., Chan A.W., Wu A., Lau C.S. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003, 48:2888-2897.
45. Papadaki H.A., Boumpas D.T., Gibson F.M., Jaye D.R., Axford J.S., Gordon-Smith E.C., et al. Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol 2001, 115:167-174.
46. Matsuyama W., Yamamoto M., Higashimoto I., Oonakahara K., Watanabe M., Machida K., et al. TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood 2004, 104:184-191.
47. Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Heamtol 2002, 39:121-127.
48. Kurien B.T., Newland J., Paczkowski C., Moore K.I., Scofield R.H. Association of neutropenia in systemic lupus erythematosus with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antien. Clin Exp Immunol 2000, 120:209-217.
49. Hsieh S.C., Yu H.S., Lin W.W., Sun K.H., Tsai C.Y., Huang D.F. Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus. Clin Exp Immunol 2003, 131:506-516.
50. Finch S.C. Neutrophil disorders-benign, quantitative abnormalities of neutrophils. Hematology 1983, 773. McGraw-Hill, New York. W.J. Williams, E. Beutler, A.J. Erslev, M.A. Lichtman (Eds.).
51. Crosby W.H. How many "polys" are enough?. Arch Intern Med 1969, 123:722-723.
52. Koene H.R., de Haas M., Kleijer M., Huizinga T.W., Roos D., von dem Borne A.E. Clinical value of soluble IgG Fc receptor type III in plasma from patients with chronic idiopathic neutropenia. Blood 1998, 91:3962-3966.
53. Tigue C.C., McKoy J.M., Evens A.M., Trifilio S.M., Tallman M.S., Bennett C.L. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant 2007, 40:185-192.
54. Rosenberg P.S., Alter B.P., Bolyard A.A., Bonilla M.A., Boxer L.A., Cham B., et al. Severe Chronic Neutropenia International Registry. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006, 107:4628-4635.
55. Donadieu J., Leblanc T., Bader Meunier B., Barkaoui M., Fenneteau O., Bertrand Y., et al. French Severe Chronic Neutropenia Study Group. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005, 90:45-53.
56. Kerst J.M., de Haas M., van der Schoot C.E., Slaper-Cortenbach I.C., Kleijer M., von dem Borne A.E., et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993, 82:3265-3272.
57. Mahevas M., Audia S., De Lastors V., Michel M., Bonotte B., Godeau B. Neutropenia in Felty's syndrome successfully treated with hydroxychloroquine. Hematologica 2007, 92:e:78-79.
58. Sordel C., Gottenberg J.E., Hellmich B., Kieffer B., Mariette X., Sibillia J. Lack of efficacy of rituximab in Felty's syndrome. Ann Rheum Dis 2005, 64:332-333.
59. Seite J.F., Shoenfeld Y., Youinou P., Hillion S. What is the contents of the magic draft IVIg?. Autoimmun Rev 2008, 7:435-439.
60. Hellmich B., Schnabel A., Gross W.L. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus Erythematosus with granulocyte colony-stimulating factor. Semin Arthritis Rhem 1999, 29:82-89.
61. Capsoni F., Sarzi-Puttini P., Zanella A. Primary and secondary autoimmune neutropenia. Arthritis Res Ther 2005, 7:208-214.
62. Jain K.K. Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol 1994, 31:213-215.
63. McMullin M.F., Finch M.B. Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash. Clin Rheumatol 1995, 14:204-208.
64. Hayat S.Q., Hearth-Holmes M., Wolf R.E. Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF). Clin Rheumatol 1995, 14:211-212.
65. Farhey Y.D., Herman J.H. Vasculitis complicating granulocyte colony stimulating factor treatment of leucopenia and infection in Felty's syndrome. J Rheumatol 1995, 22:1179-1182.
66. Yasuda M., Kihara T., Wada T., Shiokawa S., Furuta E., Suenagu Y., et al. Granulocyte colony stimulating factor induction of improved leukocytopenia with inflammatory flare in a Felty's syndrome patient. Arthritis Rheum 1994, 37:145-146.
67. Vidarsson B., Geirsson A.J., Onundarson P.T. Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in patient receiving granulocyte colony-stimulating factor for Felty's syndrome. Am J Med 1995, 98:589-591.
68. Stanworth S.J., Bhavnani M., Chattopadhya C., Miller H., Swinson D.R. Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF). Q J Med 1998, 91:49-56.
69. Krishnaswamy G., Odem C., Chi D.S., Kalbfleisch J., Baker N., Smith J.K. Resolution of neutropenia of Felty's syndrome by longterm administration of recombinant granulocyte colony stimulating factor. J Rhematol 1996, 23:763-765.
70. Kaneko T., Ogawa Y., Hirata Y., Hoshino S., Takahashi M., Oshimi K., et al. Agranulocytosis associated with granular lymphocyte leukemia: improvement of peripheral blood granulocyte count with human recombinant granulocyte colony-stimulating factor (G-CSF). Br J Haematol 1990, 74:121-122.
71. Vicers M., Stross P., Millard P., Barton C. Response of T-beta CD8+ lymphocytosis-associated neutropenia to G-CSF. Br J Haematol 1994, 87:431-433.
72. Jakubowski A., Winton E.F., Gencarelli A., Gabrilove J. Treatment of chronic neutropenia associated with large granular lymphocytosis with cyclosporine A and filgrastim. Am J Hematol 1995, 50:288-291.
73. Mulder A., De Wof J., Smit J., Van Oostveen J., Vellenga E. Correction for neutropenia by GM-CSF in patients with a large granular lymphocyte proliferation. Ann Hematol 1992, 65:91-95.
74. Krieger G., Kneba M., Vehmeyer K., Nagel G.A., Welte K. Use of recombinant granulocyte-macrophage colony stimulating factor in T-lymphocytosis with granulocytopenia. Eur J Haematol 1990, 44:205-206.
75. Thomessen C., Nissen C., Gratwohl A., Tichelli A., Stern A. Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human recombinant granulocyte-macrophage colony stimulating factor (GM-CSF). Br J Haematol 1989, 71:157-158.
76. Lamy T., LePrise P.Y., Amiot L., Drenou B., Fauchet R., Genetet N., et al. Response to granulocyte-macrophage colony stimulating factor (GM-CSF) but not to G-CSF in a case of agranulocytosis associated large granular lymphocyte (LGL) leukemia. Blood 1995, 85:3352-3362.
77. Euler H.H., Schwab U.M., Schroeder J.O. Filgrastim for lupus neutropenia. Lancet 1994, 344:1513-1514.
78. Kondo H., Date Y., Sakai Y., Akimoto M. Effective simultaneous rhG-CSF and methylprednisolone "pulse" therapy in agranulocytosis associated with systemic lupus erythematosus. Am J Hematol 1994, 46:157-158.
79. Euler H.H., Harten P., Zeuner R.A., Schwab U.M. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infection. J Rhematol 1997, 24:2153-2157.
80. Hellmich B., Csernok E., Schatz H., Gross W.L., Schanbe A. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Arthritis Rheum 2002, 46:2384-2391.
81. Vasiliu I.M., Petri M.A., Baer A.N. Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares. J Rheumatol 2006, 33:1878-1880.